Clinical Trials Browser

Non-Muscle Invasive Bladder Neoplasms × avelumab × Clear all

NCT03498196 2020-08-24

A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer

Phase 1/2 Terminated

1 enrolled 10 charts

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT03950362 2019-05-16

PREVERT

Phase 2 Unknown

Non-Muscle Invasive Bladder Neoplasms